• Home
• About Us
  • Our Company
  • Our Strategy
  • Meet the Management Team
  • Our Board Members
  • Plasma Resources
• Product Pipeline
  • R&D Pipeline
  • PBI-4050
    • Alström Syndrome
    • Idiopathic Pulmonary Fibrosis
  • Selective GPR84 Antagonist
  • Selective OXER1 Antagonist
  • Plasminogen Deficiency
  • Scientific Posters

• Investors & Media
  • Investor Resources
  • Press Releases
  • Financial Reports
  • Webcasts
  • SEC Filings
  • Stock Information
  • Corporate Governance
  • Investor Briefcase
  • Frequently Asked Questions
• Careers
  • Career Opportunities
  • Resume Submission
• Subscribe